Protalix BioTherapeutics Inc. (PLX) stock is falling in premarket, Why is this happening?
Protalix BioTherapeutics, Inc. (NYSE American: PLX) a biopharmaceutical company focused on manufacturing recombinant therapeutic proteins with clinically improved profiles, confirmed receiving